Mark Holbrook
Impact in
- Small Animals top 2%
- Animal testing and alternatives
-
- Cardiac electrophysiology and arrhythmias
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Animal testing and alternatives 5
-
- Cardiac electrophysiology and arrhythmias 6
- Co-authors
- Jean‐Pierre Valentin (3 shared papers)Neil Gozzard (3 shared papers)Susan J. Coker (2 shared papers)David J. Gallacher (1 shared paper)Noel O. Dybdal (1 shared paper)Marek Malík (1 shared paper)Brian D. Guth (1 shared paper)Brian M. Roche (1 shared paper)
- Journals
- British Journal of Pharmacology (7 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemical Pharmacology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Regulatory Toxicology and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
Mark Holbrook
25 papers receiving 756 citations
Peers
Comparison fields: 5 of 83
- Small Animals 154
- Cardiology and Cardiovascular Medicine 273
- Physiology 86
- Molecular Biology 192
- Cell Biology 39
Countries citing papers authored by Mark Holbrook
This map shows the geographic impact of Mark Holbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holbrook more than expected).
Fields of papers citing papers by Mark Holbrook
This network shows the impact of papers produced by Mark Holbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holbrook. The network helps show where Mark Holbrook may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Holbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 88 | |
| 2 | 2011 | 83 | |
| 3 | 2019 | 79 | |
| 4 | 2014 | 69 | |
| 5 | 2008 | 60 | |
| 6 | 2013 | 44 | |
| 7 | 2010 | 43 | |
| 8 | 1996 | 42 | |
| 9 | 1996 | 41 | |
| 10 | 2005 | 41 | |
| 11 | 2008 | 38 | |
| 12 | 2020 | 35 | |
| 13 | 2011 | 32 | |
| 14 | 1996 | 30 | |
| 15 | 1991 | 28 | |
| 16 | 2007 | 27 | |
| 17 | 2021 | 27 | |
| 18 | 2019 | 22 | |
| 19 | 2014 | 12 | |
| 20 | 1989 | 8 |
About Mark Holbrook
Mark Holbrook is a scholar working on Small Animals, Cardiology and Cardiovascular Medicine, Statistics and Probability, Physiology and Molecular Biology, having authored 25 papers that have together received 867 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (6 papers), Animal testing and alternatives (5 papers), Phosphodiesterase function and regulation (4 papers), Asthma and respiratory diseases (3 papers), Receptor Mechanisms and Signaling (2 papers), Synthesis and biological activity (2 papers), Statistical Methods in Clinical Trials (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Small Animals (154 citations), Cardiology and Cardiovascular Medicine (273 citations), Physiology (86 citations), Molecular Biology (192 citations) and Cell Biology (39 citations). Mark Holbrook has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include Jean‐Pierre Valentin, Neil Gozzard, Susan J. Coker, David J. Gallacher, Noel O. Dybdal, Marek Malík, Brian D. Guth, Brian M. Roche, Rashmi R. Shah and William S. Redfern. Their work appears in journals such as British Journal of Pharmacology, Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Clinical Pharmacology & Therapeutics and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.